0 results for 'Omnicare, Inc.'
Plaintiff cigarette manufacturers challenged the FDA's new rule requiring updated warning labels on cigarette packages and advertisements.
Appeals & Motions List released on:April 4, 2024
Plaintiff Fails to Plead Scienter, But Amply Pleads Documents Had Misleading Statements
State Plausibly Alleges Ghost Guns Are 'Firearms' Subject to Federal Restrictions
Second Circuit Sets Standard for Distinguishing Opinions From Facts in Securities Fraud Cases
A discussion of the case 'Union Asset Management Holding AG v. Philip Morris International Inc. (In re Philip Morris International Inc. Securities Litigation) where the Second Circuit elucidates on distinguishing fact from opinion.View more book results for the query "Omnicare, Inc."
Proxy's Financial Projections Were Accompanied by Sufficient Cautionary Language
Plaintiff Adequately Alleges Drug Company's Scienter Over Statements About FDA Approval
When Do Omissions Create Private Liability? The Supreme Court Ponders
On Jan. 16, 2024, the Supreme Court heard 'MacQuarie Infrastructure Corp. v. Moab Partners L.P.', which will presumably resolve a circuit split. The question before the court is whether the Second Circuit erred in holding "that a failure to make a disclosure required under Item 303 of SEC Regulation S-K can support a private claim under §10(b) of the Exchange Act, even in the absence of an otherwise misleading statement."Fact or Opinion? 2nd Circuit Raises Bar for Investor Fraud Suits